Key statistics
On Friday, Dyne Therapeutics Inc (DYN:NSQ) closed at 32.58, -31.34% below its 52-week high of 47.45, set on Aug 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 34.00 |
---|---|
High | 34.00 |
Low | 32.39 |
Bid | 32.05 |
Offer | 34.63 |
Previous close | 33.55 |
Average volume | 1.08m |
---|---|
Shares outstanding | 100.40m |
Free float | 99.90m |
P/E (TTM) | -- |
Market cap | 3.27bn USD |
EPS (TTM) | -3.58 USD |
Data delayed at least 15 minutes, as of Oct 04 2024 21:00 BST.
More ▼
Announcements
- Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
- Dyne Therapeutics Announces Key Leadership Appointments
- Dyne Therapeutics Announces New Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented Dystrophin Expression and Functional Improvement in Multiple Cohorts
- Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
- Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
- Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE™ Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease
- Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress
- Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
- Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
- Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
More ▼